INmune Bio Announces Publication of Myeloid-Derived Suppressor Cells (MDSC) Report in the Cell’s Trends in Pharmacological Sciences Journal
December 07, 2018 09:00 ET
|
INmune Bio, Inc.
Manuscript highlights the vital role of MDSC in the tumor microenvironment (TME) LA JOLLA, Calif.,, Dec. 07, 2018 (GLOBE NEWSWIRE) -- INmune Bio Inc., an immunotherapy company developing...
INmune Nominated for Buzz of Bio Award at 2019 CEO & Investor Conference
December 04, 2018 08:30 ET
|
INmune Bio, Inc.
-Voting begins today: Click here to cast your vote- LA JOLLA, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- INmune Bio, Inc., an immunotherapy company focused on developing therapies that harness...
Greenpro Capital Corp. Announces Launch of ADAQ and Collaboration with PIKOM and SEATech Ventures
December 03, 2018 08:30 ET
|
Greenpro Capital Corp.
Hong Kong, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Greenpro Capital Corp. ("Greenpro" or the "Company") (Nasdaq:GRNQ), a multinational conglomerate with a diversified capital portfolio, today announced...
Greenpro Capital Corp. Holds Annual “Worldwide Wealth Wisdom” Summit
November 28, 2018 16:30 ET
|
Greenpro Capital Corp.
Hong Kong, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Greenpro Capital Corp. ("Greenpro" or the "Company") (Nasdaq:GRNQ), a multinational conglomerate with a diversified capital portfolio, today announced...